Maureen Jonas' research focuses on liver disease in children, with emphasis on viral hepatitis. She was the principal investigator in the multicenter International Pediatric Lamivudine Trial, and is currently studying the safety and efficacy of other drugs, adefovir dipivoxil and entecavir, in children with chronic hepatitis B. She is the principle site investigator for PEDS-C, an NIH sponsored study of the treatment of chronic hepatitis C in children. Other research involves looking at non-invasive ways to detect and measure fibrosis (scarring) in the liver, and some of the metabolic effects of chronic hepatitis C. She participates in an international epidemiologic study of hepatitis B in children, and the national Studies of Pediatric Liver Transplantation (SPLIT.)


Maureen Jonas received her MD degree from University of Miami School of Medicine. She completed internship and residency in General Pediatrics, and fellowship in Pediatric Gastroenterology, at Boston Children's Hospital. She is certified in Pediatric Gastroenterology and Pediatric Transplant Hepatology. Dr. Jonas has served on the Executive Council of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) and numerous committees of the American Association for the Study of Liver Diseases. She is a member of the Medical Advisory Committee of the New England Chapter of the American Liver Foundation. She is the director of the Center for Childhood Liver Disease and the Medical Director of the Liver Transplant Program at Boston Children’s Hospital. She is also the Director of the 4th year Advanced Hepatology Fellowship at Children’s. Dr. Jonas recently edited a book on Viral Hepatitis in Children.


Publications powered by Harvard Catalyst Profiles

  1. Fahmy DM, Shokeir M, El Zeiny SM, Jonas MM, Abdallah A. Changes in Liver Stiffness and Non-Invasive Fibrosis Scores in Egyptian Adolescents Successfully Treated with Ledipasvir-Sofosbuvir for Chronic HCV Infection. J Pediatr. 2020 Dec 18. View abstract
  2. Chappell CA, Jonas MM. Hepatitis C Virus in Pregnancy: Are We Ready for Test and Treat? J Infect Dis. 2020 Nov 27; 222(Supplement_9):S789-S793. View abstract
  3. Deneau MR, Mack C, Mogul D, Perito ER, Valentino PL, Amir AZ, DiGuglielmo M, Draijer LG, El-Matary W, Furuya KN, Gupta N, Hochberg JT, Horslen S, Jensen MK, Jonas MM, Kerkar N, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Martinez M, Miethke A, Miloh T, Mohammad S, Ovchinsky N, Rao G, Ricciuto A, Sathya P, Schwarz KB, Shah U, Singh R, Vitola B, Zizzo A, Guthery SL. Oral vancomycin, ursodeoxycholic acid or no therapy for pediatric primary sclerosing cholangitis: a matched analysis. Hepatology. 2020 Sep 18. View abstract
  4. Deneau MR, Mack C, Perito ER, Ricciuto A, Valentino PL, Amin M, Amir AZ, Aumar M, Auth M, Broderick A, DiGuglielmo M, Draijer LG, Tavares Fagundes ED, El-Matary W, Ferrari F, Furuya KN, Gupta N, Hochberg JT, Homan M, Horslen S, Iorio R, Jensen MK, Jonas MM, Kamath BM, Kerkar N, Kim KM, Kolho KL, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Martinez M, Miethke A, Miloh T, Mogul D, Mohammad S, Mohan P, Moroz S, Ovchinsky N, Palle S, Papadopoulou A, Rao G, Rodrigues Ferreira A, Sathya P, Schwarz KB, Shah U, Shteyer E, Singh R, Smolka V, Soufi N, Tanaka A, Varier R, Vitola B, Woynarowski M, Zerofsky M, Zizzo A, Guthery SL. The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children. Hepatology. 2020 May 28. View abstract
  5. Rosenthal P, Narkewicz MR, Yao BB, Jolley CD, Lobritto SJ, Wen J, Molleston JP, Hsu EK, Jonas MM, Zha J, Liu L, Leung DH. Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Mini-Tabs Plus Ribavirin for Children Aged 3-11 Years with Hepatitis C Genotype 1a. Adv Ther. 2020 07; 37(7):3299-3310. View abstract
  6. Lee CK, Nastasio S, Mitchell PD, Fawaz R, Elisofon SA, Vakili K, Kim HB, Nguyen D, Jonas MM. Transient elastography assessment of liver allograft fibrosis in pediatric transplant recipients. Pediatr Transplant. 2020 09; 24(6):e13736. View abstract
  7. Ibrahim SH, Jonas MM, Taylor SA, Gutierrez Sanchez LH, Wolf JL, Sundaram SS. Liver Diseases in the Perinatal Period: Interactions Between Mother and Infant. Hepatology. 2020 Apr; 71(4):1474-1485. View abstract
  8. Ghany MG, Morgan TR. Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology. 2020 02; 71(2):686-721. View abstract
  9. Pai AK, Jonas MM, Fox VL. Esophageal Capsule Endoscopy in Children and Young Adults With Portal Hypertension. J Pediatr Gastroenterol Nutr. 2019 12; 69(6):641-647. View abstract
  10. Nastasio S, Jonas MM. Effect of Universal Infant Hepatitis B Virus Immunization on Mother-to-Child Hepatitis B Virus Transmission. J Infect Dis. 2019 08 30; 220(7):1089-1090. View abstract
  11. Rosenthal P, Schwarz KB, Gonzalez-Peralta RP, Lin CH, Kelly DA, Nightingale S, Balistreri WF, Bansal S, Jonas MM, Massetto B, Brainard DM, Hsueh CH, Shao J, Parhy B, Davison S, Feiterna-Sperling C, Gillis LA, Indolfi G, Sokal EM, Murray KF, Wirth S. Sofosbuvir and Ribavirin Therapy for Children Aged 3 to <12 Years With Hepatitis C Virus Genotype 2 or 3 Infection. Hepatology. 2020 01; 71(1):31-43. View abstract
  12. Jonas MM, Squires RH, Rhee SM, Lin CW, Bessho K, Feiterna-Sperling C, Hierro L, Kelly D, Ling SC, Strokova T, Del Valle-Segarra A, Lovell S, Liu W, Ng TI, Porcalla A, Gonzalez YS, Burroughs M, Sokal E. Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study. Hepatology. 2020 02; 71(2):456-462. View abstract
  13. Indolfi G, Easterbrook P, Dusheiko G, El-Sayed MH, Jonas MM, Thorne C, Bulterys M, Siberry G, Walsh N, Chang MH, Meyers T, Giaquinto C, Wirth S, Chan PL, Penazzato M. Hepatitis C virus infection in children and adolescents. Lancet Gastroenterol Hepatol. 2019 06; 4(6):477-487. View abstract
  14. Indolfi G, Easterbrook P, Dusheiko G, Siberry G, Chang MH, Thorne C, Bulterys M, Chan PL, El-Sayed MH, Giaquinto C, Jonas MM, Meyers T, Walsh N, Wirth S, Penazzato M. Hepatitis B virus infection in children and adolescents. Lancet Gastroenterol Hepatol. 2019 06; 4(6):466-476. View abstract
  15. Desai NK, Mendelson MM, Baker A, Ryan HH, Griggs S, Boghani M, Yellen E, Buckley L, Gillman MW, Zachariah JP, Graham D, Jonas MM, de Ferranti SD. Hepatotoxicity of Statins as Determined by Serum Alanine Aminotransferase in a Pediatric Cohort With Dyslipidemia. J Pediatr Gastroenterol Nutr. 2019 02; 68(2):175-181. View abstract
  16. Bader RM, Jonas MM, Mitchell PD, Wiggins S, Lee CK. Controlled attenuation parameter: A measure of hepatic steatosis in patients with cystic fibrosis. J Cyst Fibros. 2019 03; 18(2):280-285. View abstract
  17. Murray KF, Balistreri WF, Bansal S, Whitworth S, Evans HM, Gonzalez-Peralta RP, Wen J, Massetto B, Kersey K, Shao J, Garrison KL, Parhy B, Brainard DM, Arnon R, Gillis LA, Jonas MM, Lin CH, Narkewicz MR, Schwarz K, Rosenthal P. Safety and Efficacy of Ledipasvir-Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6-11. Hepatology. 2018 12; 68(6):2158-2166. View abstract
  18. Jhaveri R, Broder T, Bhattacharya D, Peters MG, Kim AY, Jonas MM. Universal Screening of Pregnant Women for Hepatitis C: The Time Is Now. Clin Infect Dis. 2018 10 30; 67(10):1493-1497. View abstract
  19. Leung DH, Wirth S, Yao BB, Viani RM, Gonzalez-Peralta RP, Jonas MM, Lobritto SJ, Narkewicz MR, Sokal E, Fortuny C, Hsu EK, Del Valle-Segarra A, Zha J, Larsen L, Liu L, Shuster DL, Cohen DE, Rosenthal P. Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4. Hepatol Commun. 2018 Nov; 2(11):1311-1319. View abstract
  20. Terrault NA, Brown RS, Lok AS, Wong JB, Bzowej NH, Chang KM, Hwang JP, Jonas MM, McMahon BJ. Reply. Hepatology. 2018 10; 68(4):1658-1660. View abstract
  21. Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS, Bzowej NH, Wong JB. Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance. Clin Liver Dis (Hoboken). 2018 Jul; 12(1):33-34. View abstract
  22. Lee CK, Mitchell PD, Raza R, Harney S, Wiggins SM, Jonas MM. Validation of Transient Elastography Cut Points to Assess Advanced Liver Fibrosis in Children and Young Adults: The Boston Children's Hospital Experience. J Pediatr. 2018 07; 198:84-89.e2. View abstract
  23. Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS, Bzowej NH, Wong JB. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018 04; 67(4):1560-1599. View abstract
  24. Rajabi F, Rodan LH, Jonas MM, Soul JS, Ullrich NJ, Wessel A, Waisbren SE, Tan WH, Berry GT. Liver Failure as the Presentation of Ornithine Transcarbamylase Deficiency in a 13-Month-Old Female. JIMD Rep. 2018; 40:17-22. View abstract
  25. Wirth S, Rosenthal P, Gonzalez-Peralta RP, Jonas MM, Balistreri WF, Lin CH, Hardikar W, Kersey K, Massetto B, Kanwar B, Brainard DM, Shao J, Svarovskaia E, Kirby B, Arnon R, Murray KF, Schwarz KB. Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection. Hepatology. 2017 10; 66(4):1102-1110. View abstract
  26. Balistreri WF, Murray KF, Rosenthal P, Bansal S, Lin CH, Kersey K, Massetto B, Zhu Y, Kanwar B, German P, Svarovskaia E, Brainard DM, Wen J, Gonzalez-Peralta RP, Jonas MM, Schwarz K. The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection. Hepatology. 2017 08; 66(2):371-378. View abstract
  27. Aqul A, Jonas MM, Harney S, Raza R, Sawicki GS, Mitchell PD, Fawaz R. Correlation of Transient Elastography With Severity of Cystic Fibrosis-related Liver Disease. J Pediatr Gastroenterol Nutr. 2017 04; 64(4):505-511. View abstract
  28. Raizner A, Shillingford N, Mitchell PD, Harney S, Raza R, Serino J, Jonas MM, Lee CK. Hepatic Inflammation May Influence Liver Stiffness Measurements by Transient Elastography in Children and Young Adults. J Pediatr Gastroenterol Nutr. 2017 04; 64(4):512-517. View abstract
  29. Saubermann LJ, Deneau M, Falcone RA, Murray KF, Ali S, Kohli R, Ekong UD, Valentino PL, Grossman AB, Rand EB, Jonas MM, Saeed SA, Kamath BM. Hepatic Issues and Complications Associated With Inflammatory Bowel Disease: A Clinical Report From the NASPGHAN Inflammatory Bowel Disease and Hepatology Committees. J Pediatr Gastroenterol Nutr. 2017 04; 64(4):639-652. View abstract
  30. Valentino PL, Wiggins S, Harney S, Raza R, Lee CK, Jonas MM. The Natural History of Primary Sclerosing Cholangitis in Children: A Large Single-Center Longitudinal Cohort Study. J Pediatr Gastroenterol Nutr. 2016 12; 63(6):603-609. View abstract
  31. Velasquez T, Mackey G, Lusk J, Kyle UG, Fontenot T, Marshall P, Shekerdemian LS, Coss-Bu JA, Nishigaki A, Yatabe T, Tamura T, Yamashita K, Yokoyama M, Ruiz-Rodriguez JC, Encina B, Belmonte R, Troncoso I, Tormos P, Riveiro M, Baena J, Sanchez A, Bañeras J, Cordón J, Duran N, Ruiz A, Caballero J, Nuvials X, Riera J, Serra J, Rutten AM, van Ieperen SN, Der Kinderen EP, Van Logten T, Kovacikova L, Skrak P, Zahorec M, Kyle UG, Akcan-Arikan A, Silva JC, Mackey G, Lusk J, Goldsworthy M, Shekerdemian LS, Coss-Bu JA, Wood D, Harrison D, Parslow R, Davis P, Pappachan J, Goodwin S, Ramnarayan P, Chernyshuk S, Yemets H, Zhovnir V, Pulitano' SM, De Rosa S, Mancino A, Villa G, Tosi F, Franchi P, Conti G, Patel B, Khine H, Shah A, Sung D, Singer L, Haghbin S, Inaloo S, Serati Z, Idei M, Nomura T, Yamamoto N, Sakai Y, Yoshida T, Matsuda Y, Yamaguchi Y, Takaki S, Yamaguchi O, Goto T, Longani N, Medar S, Abdel-Aal IR, El Adawy AS, Mohammed HM, Mohamed AN, Parry SM, Knight LD, Denehy L, De Morton N, Baldwin CE, Sani D, Kayambu G, da Silva VZ, Phongpagdi P, Puthucheary ZA, Granger CL, Rydingsward JE, Horkan CM, Christopher KB, McWilliams D, Jones C, Reeves E, Atkins G, Snelson C, Aitken LM, Rattray J, Kenardy J, Hull AM, Ullman A, Le Brocque R, Mitchell M, Davis C, Macfarlane B, Azevedo JC, Rocha LL, De Freitas FF, Cavalheiro AM, Lucinio NM, Lobato MS, Ebeling G, Kraegpoeth A, Laerkner E, De Brito-Ashurst I, White C, Gregory S, Forni LG, Flowers E, Curtis A, Wood CA, Siu K, Venkatesan K, Muhammad JB, Ng L, Seet E, Baptista N, Escoval A, Tomas E, Agrawal R, Mathew R, Varma A, Dima E, Charitidou E, Perivolioti E, Pratikaki M, Vrettou C, Giannopoulos A, Zakynthinos S, Routsi C, Atchade E, Houzé S, Jean-Baptiste S, Thabut G, Genève C, Tanaka S, Lortat-Jacob B, Augustin P, Desmard M, Montravers P, de Molina FJ, Barbadillo S, Alejandro R, Álvarez-Lerma F, Vallés J, Catalán RM, Palencia E, Jareño A, Granada RM, Ignacio ML, Cui N, Liu D, Wang H, Su L, Qiu H, Li R, Jaffal K, Rouzé A, Poissy J, Sendid B, Nseir S, Paramythiotou E, Rizos M, Frantzeskaki F, Antoniadou A, Vourli S, Zerva L, Armaganidis A, Riera J, Gottlieb J, Greer M, Wiesner O, Martínez M, Acuña M, Rello J, Welte T, Atchade E, Mignot T, Houzé S, Jean-Baptiste S, Thabut G, Lortat-Jacob B, Tanaka S, Augustin P, Desmard M, Montravers P, Soussi S, Dudoignon E, Ferry A, Chaussard M, Benyamina M, Alanio A, Touratier S, Chaouat M, Lafaurie M, Mimoun M, Mebazaa A, Legrand M, Sheils MA, Patel C, Mohankumar L, Akhtar N, Noriega SK, Aldana NN, León JL, Baquero JD, Bernal FF, Ahmadnia E, Hadley JS, Millar M, Hall D, Hewitt H, Yasuda H, Sanui M, Komuro T, Kawano S, Andoh K, Yamamoto H, Noda E, Hatakeyama J, Saitou N, Okamoto H, Kobayashi A, Takei T, Matsukubo S, Rotzel HB, Lázaro AS, Prada DA, Gimillo MR, Barinas OD, Cortes ML, Franco JF, Roca JM, Carratalá A, Gonçalves B, Turon R, Mendes A, Miranda F, Mata PJ, Cavalcanti D, Melo N, Lacerda P, Kurtz P, Righy C, Rosario LE, Lesmes SP, Romero JC, Herrera AN, Pertuz ED, Sánchez MJ, Sanz ER, Hualde JB, Hernández AA, Irazabal JM, Spatenkova V, Bradac O, Suchomel P, Urli T, Lazzeri EH, Aspide R, Zanello M, Perez-Borrero L, Garcia-Alvarez JM, Arias-Verdu MD, Aguilar-Alonso E, Rivera-Fernandez R, Mora-Ordoñez J, De La Fuente-Martos C, Castillo-Lorente E, Guerrero-Lopez F, Lesmes SP, Rosario LE, Pertuz ED, Hernández AA, Romero JC, Sánchez MJ, Herrera AN, Ramírez JR, Sanz ER, Hualde JB, León JP, Navarro-Guillamón L, Cordovilla-Guardia S, Iglesias-Santiago A, Guerrero-López F, Fernández-Mondéjar E, Vidal A, Perez M, Juez A, Arias N, Colino L, Perez JL, Pérez H, Calpe P, Alcala MA, Robaglia D, Perez C, Lan SK, Cunha MM, Moreira T, Santos F, Lafuente E, Fernandes MJ, Silva JG, Rosario LE, Lesmes SP, Herrera AN, Romero JC, Pertuz ED, Sánchez MJ, Sanz ER, Echeverría JG, Hernández AA, Hualde JB, Podlepich V, Sokolova E, Alexandrova E, Lapteva K, Kurtz P, Shuinotsuka C, Rabello L, Vianna G, Reis A, Cairus C, Salluh J, Bozza F, Torres JC, Araujo NJ, et al. ESICM LIVES 2016: part three : Milan, Italy. 1-5 October 2016. Intensive Care Med Exp. 2016 Sep; 4(Suppl 1):28. View abstract
  32. Wasiak D, Jonas M, Lagiewska B, Cieciura T, Malkowski P, Chmura A. Delayed, Uncommon Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Case Report. Transplant Proc. 2016 Jun; 48(5):1855-7. View abstract
  33. Valentino PL, Jonas MM, Lee CK, Kim HB, Vakili K, Elisofon SA. Outcomes after discontinuation of routine use of transanastomotic biliary stents in pediatric liver transplantation at a single site. Pediatr Transplant. 2016 Aug; 20(5):647-51. View abstract
  34. Desai NK, Harney S, Raza R, Al-Ibraheemi A, Shillingford N, Mitchell PD, Jonas MM. Comparison of Controlled Attenuation Parameter and Liver Biopsy to Assess Hepatic Steatosis in Pediatric Patients. J Pediatr. 2016 06; 173:160-164.e1. View abstract
  35. Schwarz KB, Molleston JP, Jonas MM, Wen J, Murray KF, Rosenthal P, Gonzalez-Peralta RP, Lobritto SJ, Mogul D, Pavlovic V, Warne C, Wat C, Thompson B. Durability of Response in Children Treated With Pegylated Interferon alfa [corrected] 2a ± Ribavirin for Chronic Hepatitis C. J Pediatr Gastroenterol Nutr. 2016 Jan; 62(1):93-6. View abstract
  36. Jonas MM, Lok AS, McMahon BJ, Brown RS, Wong JB, Ahmed AT, Farah W, Mouchli MA, Singh S, Prokop LJ, Murad MH, Mohammed K. Antiviral therapy in management of chronic hepatitis B viral infection in children: A systematic review and meta-analysis. Hepatology. 2016 Jan; 63(1):307-18. View abstract
  37. Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016 Jan; 63(1):261-83. View abstract
  38. Jonas MM, Chang MH, Sokal E, Schwarz KB, Kelly D, Kim KM, Ling SC, Rosenthal P, Oraseanu D, Reynolds L, Thiry A, Ackerman P. Randomized, controlled trial of entecavir versus placebo in children with hepatitis B envelope antigen-positive chronic hepatitis B. Hepatology. 2016 Feb; 63(2):377-87. View abstract
  39. Lee CK, Jonas MM. Hepatitis C: Issues in Children. Gastroenterol Clin North Am. 2015 Dec; 44(4):901-9. View abstract
  40. Tucker SM, Jonas MM, Perez-Atayde AR. Hyaline droplets in Kupffer cells: a novel diagnostic clue for autoimmune hepatitis. Am J Surg Pathol. 2015 Jun; 39(6):772-8. View abstract
  41. Lee CK, Jonas MM. Treating HCV infection in children. Clin Liver Dis (Hoboken). 2015 Jan; 5(1):14-16. View abstract
  42. Wu FM, Jonas MM, Opotowsky AR, Harmon A, Raza R, Ukomadu C, Landzberg MJ, Singh MN, Valente AM, Egidy Assenza G, Perez-Atayde AR. Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes. J Heart Lung Transplant. 2015 Jul; 34(7):883-91. View abstract
  43. Delgado-Borrego A, Gonzalez-Peralta RP, Raza R, Negre B, Goodman ZD, Jonas MM, Chung RT, Ludwig DA. Correlates of adiponectin in hepatitis C-infected children: the importance of body mass index. J Pediatr Gastroenterol Nutr. 2015 Feb; 60(2):165-70. View abstract
  44. Jonas MM, Schwarz KB, Gonzalez-Peralta R, Lobritto S, Molleston JP, Murray KF, Rosenthal P, Wen J, Wat C, Pavlovic V, Warne C. Long-term growth outcomes in children treated for chronic hepatitis C. J Pediatr. 2014 Dec; 165(6):1252-4. View abstract
  45. Wu FM, Opotowsky AR, Raza R, Harney S, Ukomadu C, Landzberg MJ, Valente AM, Breitbart RE, Singh MN, Gauvreau K, Jonas MM. Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis. Congenit Heart Dis. 2014 Sep-Oct; 9(5):438-47. View abstract
  46. Govender P, Jonas MM, Alomari AI, Padua HM, Dillon BJ, Landrigan-Ossar MF, Chaudry G. Sonography-guided percutaneous liver biopsies in children. AJR Am J Roentgenol. 2013 Sep; 201(3):645-50. View abstract
  47. Lee CK, Perez-Atayde AR, Mitchell PD, Raza R, Afdhal NH, Jonas MM. Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a United States cohort: the Boston children's hospital experience. J Pediatr. 2013 Oct; 163(4):1058-64.e2. View abstract
  48. Ramon-Krauel M, Salsberg SL, Ebbeling CB, Voss SD, Mulkern RV, Apura MM, Cooke EA, Sarao K, Jonas MM, Ludwig DS. A low-glycemic-load versus low-fat diet in the treatment of fatty liver in obese children. Child Obes. 2013 Jun; 9(3):252-60. View abstract
  49. Molleston JP, Mellman W, Narkewicz MR, Balistreri WF, Gonzalez-Peralta RP, Jonas MM, Lobritto SJ, Mohan P, Murray KF, Njoku D, Rosenthal P, Barton BA, Talor MV, Cheng I, Schwarz KB, Haber BA. Autoantibodies and autoimmune disease during treatment of children with chronic hepatitis C. J Pediatr Gastroenterol Nutr. 2013 Mar; 56(3):304-10. View abstract
  50. Jonas MM. Hepatitis B virus infection in children. Clin Liver Dis (Hoboken). 2013 Feb; 2(1):41-44. View abstract
  51. Jonas MM, Balistreri W, Gonzalez-Peralta RP, Haber B, Lobritto S, Mohan P, Molleston JP, Murray KF, Narkewicz MR, Rosenthal P, Schwarz KB, Barton BA, Shepherd JA, Mitchell PD, Duggan C. Pegylated interferon for chronic hepatitis C in children affects growth and body composition: results from the pediatric study of hepatitis C (PEDS-C) trial. Hepatology. 2012 Aug; 56(2):523-31. View abstract
  52. Delgado-Borrego A, Smith L, Jonas MM, Hall CA, Negre B, Jordan SH, Ogrodowicz M, Raza R, Ludwig DA, Miller T, Lipshultz SE, Gonzalez-Peralta R, Chung RT. Expected and actual case ascertainment and treatment rates for children infected with hepatitis C in Florida and the United States: epidemiologic evidence from statewide and nationwide surveys. J Pediatr. 2012 Nov; 161(5):915-21. View abstract
  53. Cauley RP, Suh MY, Kamin DS, Lillehei CW, Jenkins RL, Jonas MM, Vakili K, Kim HB. Multivisceral transplantation using a 2.9 kg neonatal donor. Pediatr Transplant. 2012 Dec; 16(8):E379-82. View abstract
  54. Jonas MM, Kelly D, Pollack H, Mizerski J, Sorbel J, Frederick D, Mondou E, Rousseau F, Sokal E. Efficacy and safety of long-term adefovir dipivoxil therapy in children with chronic hepatitis B infection. Pediatr Infect Dis J. 2012 Jun; 31(6):578-82. View abstract
  55. Kelly DA, Haber B, González-Peralta RP, Murray KF, Jonas MM, Molleston JP, Narkewicz MR, Sinatra FR, Lang T, Lachaux A, Wirth S, Shelton M, Te HS, Pollack H, Deng W, Noviello S, Albrecht JK. Durability of sustained response shown in paediatric patients with chronic hepatitis C who were treated with interferon alfa-2b plus ribavirin. J Viral Hepat. 2012 Apr; 19(4):263-70. View abstract
  56. Rodrigue JR, Balistreri W, Haber B, Jonas MM, Mohan P, Molleston JP, Murray KF, Narkewicz MR, Rosenthal P, Smith LJ, Lobritto SJ, Schwarz KB, Robuck PR, Barton B, González-Peralta RP. Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in children. Hepatology. 2011 May; 53(5):1468-75. View abstract
  57. Jonas MM. Hepatitis A virus infection: progress made, more work to be done. J Pediatr (Rio J). 2011 May-Jun 8; 87(3):185-6. View abstract
  58. Schwarz KB, Gonzalez-Peralta RP, Murray KF, Molleston JP, Haber BA, Jonas MM, Rosenthal P, Mohan P, Balistreri WF, Narkewicz MR, Smith L, Lobritto SJ, Rossi S, Valsamakis A, Goodman Z, Robuck PR, Barton BA. The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C. Gastroenterology. 2011 Feb; 140(2):450-458.e1. View abstract
  59. Jonas MM, Block JM, Haber BA, Karpen SJ, London WT, Murray KF, Narkewicz MR, Rosenthal P, Schwarz KB, McMahon BJ. Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options. Hepatology. 2010 Dec; 52(6):2192-205. View abstract
  60. Delgado-Borrego A, Healey D, Negre B, Christofi M, Sabharwal S, Ludwig DA, Chung RT, Jonas MM. Influence of body mass index on outcome of pediatric chronic hepatitis C virus infection. J Pediatr Gastroenterol Nutr. 2010 Aug; 51(2):191-7. View abstract
  61. McGuire MM, Jones BA, Hull MA, Misra MV, Smithers CJ, Feins NR, Jenkins RL, Lillehei CW, Harmon WE, Jonas MM, Kim HB. Combined en bloc liver-double kidney transplantation in an infant with IVC thrombosis. Pediatr Transplant. 2011 Nov; 15(7):E142-4. View abstract
  62. Haber BA, Block JM, Jonas MM, Karpen SJ, London WT, McMahon BJ, Murray KF, Narkewicz MR, Rosenthal P, Schwarz KB. Recommendations for screening, monitoring, and referral of pediatric chronic hepatitis B. Pediatrics. 2009 Nov; 124(5):e1007-13. View abstract
  63. Rodrigue JR, Balistreri W, Haber B, Jonas MM, Mohan P, Molleston JP, Murray KF, Narkewicz MR, Rosenthal P, Smith LJ, Schwarz KB, Robuck P, Barton B, González-Peralta RP. Impact of hepatitis C virus infection on children and their caregivers: quality of life, cognitive, and emotional outcomes. J Pediatr Gastroenterol Nutr. 2009 Mar; 48(3):341-7. View abstract
  64. Jonas MM. Hepatitis B and pregnancy: an underestimated issue. Liver Int. 2009 Jan; 29 Suppl 1:133-9. View abstract
  65. Harmatz P, Jonas MM, Kwiatkowski JL, Wright EC, Fischer R, Vichinsky E, Giardina PJ, Neufeld EJ, Porter J, Olivieri N. Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia. Haematologica. 2008 Aug; 93(8):1247-51. View abstract
  66. Smith LM, Nesterova A, Ryan MC, Duniho S, Jonas M, Anderson M, Zabinski RF, Sutherland MK, Gerber HP, Van Orden KL, Moore PA, Ruben SM, Carter PJ. CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. Br J Cancer. 2008 Jul 08; 99(1):100-9. View abstract
  67. Jonas MM, Kelly D, Pollack H, Mizerski J, Sorbel J, Frederick D, Mondou E, Rousseau F, Sokal E. Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B. Hepatology. 2008 Jun; 47(6):1863-71. View abstract
  68. Suh MY, Wang K, Gutweiler JR, Misra MV, Krawczuk LE, Jenkins RL, Lillehei CW, Jonas MM, Kim HB. Safety of minimal immunosuppression in liver transplantation for hepatoblastoma. J Pediatr Surg. 2008 Jun; 43(6):1148-52. View abstract
  69. Fong HF, Divasta AD, Difabio D, Ringelheim J, Jonas MM, Gordon CM. Prevalence and predictors of abnormal liver enzymes in young women with anorexia nervosa. J Pediatr. 2008 Aug; 153(2):247-53. View abstract
  70. Goodman ZD, Makhlouf HR, Liu L, Balistreri W, Gonzalez-Peralta RP, Haber B, Jonas MM, Mohan P, Molleston JP, Murray KF, Narkewicz MR, Rosenthal P, Smith LJ, Robuck PR, Schwarz KB. Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial. Hepatology. 2008 Mar; 47(3):836-43. View abstract
  71. Jonas MM, Little NR, Gardner SD. Long-term lamivudine treatment of children with chronic hepatitis B: durability of therapeutic responses and safety. J Viral Hepat. 2008 Jan; 15(1):20-7. View abstract
  72. Pall H, Zielenski J, Jonas MM, DaSilva DA, Potvin KM, Yuan XW, Huang Q, Freedman SD. Primary sclerosing cholangitis in childhood is associated with abnormalities in cystic fibrosis-mediated chloride channel function. J Pediatr. 2007 Sep; 151(3):255-9. View abstract
  73. Lee CK, Jonas MM. Pediatric hepatobiliary disease. Curr Opin Gastroenterol. 2007 May; 23(3):306-9. View abstract
  74. Modi BP, Suh MY, Jonas MM, Lillehei C, Kim HB. Ileal exclusion for refractory symptomatic cholestasis in Alagille syndrome. J Pediatr Surg. 2007 May; 42(5):800-5. View abstract
  75. Jonas MM. Finding adolescents and young adults with transfusion-associated hepatitis C: looking forward to looking back. Arch Pediatr Adolesc Med. 2007 Feb; 161(2):202-3. View abstract
  76. Neff GW, Kemmer N, Zacharias VC, Kaiser T, Duncan C, McHenry R, Jonas M, Novick D, Williamson C, Hess K, Thomas M, Buell J. Analysis of hospitalizations comparing rifaximin versus lactulose in the management of hepatic encephalopathy. Transplant Proc. 2006 Dec; 38(10):3552-5. View abstract
  77. Jonas MM. Treatment of chronic hepatitis B in children. J Pediatr Gastroenterol Nutr. 2006 Jul; 43 Suppl 1:S56-60. View abstract
  78. Squires RH, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, Dhawan A, Rosenthal P, Rodriguez-Baez N, Murray KF, Horslen S, Martin MG, Lopez MJ, Soriano H, McGuire BM, Jonas MM, Yazigi N, Shepherd RW, Schwarz K, Lobritto S, Thomas DW, Lavine JE, Karpen S, Ng V, Kelly D, Simonds N, Hynan LS. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006 May; 148(5):652-658. View abstract
  79. Elisofon SA, Jonas MM. Hepatitis B and C in children: current treatment and future strategies. Clin Liver Dis. 2006 Feb; 10(1):133-48, vii. View abstract
  80. Sokal EM, Kelly DA, Mizerski J, Badia IB, Areias JA, Schwarz KB, Vegnente A, Little NR, Gardener SD, Jonas MM. Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B. Hepatology. 2006 Feb; 43(2):225-32. View abstract
  81. Jonas MM, Lee C. Review. Gastroenterol Hepatol (N Y). 2006 Feb; 2(2):90. View abstract
  82. Berg CL, Jonas MM, Bacon BR. Treatment of hereditary hemochromatosis, Wilson Disease, and other metabolic disorders of the liver. Therapy in Digestive Diseases (MM Wolfe, ed.). 2006; 487-502. View abstract
  83. Elisofon SA, Jonas MM. Hepatitis B and C in Children: Current treatment and future strategies. Clinics in Liver Disease (J Bezerra and WF Balistreri, eds.). 2006; 10:133-148. View abstract
  84. Jonas MM. The role of liver transplantation in cystic fibrosis re-examined. Liver Transpl. 2005 Dec; 11(12):1463-5. View abstract
  85. Smektala R, Ohmann C, Paech S, Neuhaus E, Rieger M, Schwabe W, Debold P, Deimling A, Jonas M, Hupe K, Bücker-Nott HJ, Giani G, Szucs TD, Pientka L. [On the prognosis of hip fractures. Assessment of mortality after hip fractures by analyzing overlapping segments of longitudinal data]. Unfallchirurg. 2005 Nov; 108(11):927-8, 930-37. View abstract
  86. González-Peralta RP, Kelly DA, Haber B, Molleston J, Murray KF, Jonas MM, Shelton M, Mieli-Vergani G, Lurie Y, Martin S, Lang T, Baczkowski A, Geffner M, Gupta S, Laughlin M. Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics. Hepatology. 2005 Nov; 42(5):1010-8. View abstract
  87. Kim HB, Pomposelli JJ, Lillehei CW, Jenkins RL, Jonas MM, Krawczuk LE, Fishman SJ. Mesogonadal shunts for extrahepatic portal vein thrombosis and variceal hemorrhage. Liver Transpl. 2005 Nov; 11(11):1389-94. View abstract
  88. Pall H, Jonas MM. Pediatric hepatobiliary disease. Curr Opin Gastroenterol. 2005 May; 21(3):344-7. View abstract
  89. Jonas MM, Krawczuk LE, Kim HB, Lillehei C, Perez-Atayde A. Rapid recurrence of nonalcoholic fatty liver disease after transplantation in a child with hypopituitarism and hepatopulmonary syndrome. Liver Transpl. 2005 Jan; 11(1):108-10. View abstract
  90. Broderick AM, Jonas MM. Management of hepatitis B infection in children. UpToDate (CD ROM) (BD Rose, ed.). 2005. View abstract
  91. Godra A, Jonas MM, Perez-Atayde AR. Histopathology of the liver in children with chronic hepatitis B (abstract). Modern Pathology. 2005; 18:312. View abstract
  92. Godra A, Perez-Atayde AR, Jonas MM. Histopathologic features of chronic hepatitis B in children (abstract). Hepatology. 2005; 42 (suppl):478-9(A). View abstract
  93. Riedlinger WFJ, Pall H, Jonas MM, Fox VL, Perez-Atayde AR. Primary sclerosing cholangitis: a clinicopathologic study in 31 children (abstract). Modern Pathology. 2005; 18:305. View abstract
  94. Jonas MM. Hepatitis C virus infectionin children. UpToDate (CD ROM) (BD Rose, ed.). 2005. View abstract
  95. Delgado-Borrego A, Jonas MM. Treatment Options for Hepatitis C Infection in Children. Curr Treat Options Gastroenterol. 2004 Oct; 7(5):373-379. View abstract
  96. Chang MH, Hadzic D, Rouassant SH, Jonas M, Kohn IJ, Negro F, Roberts E, Sibal A. Acute and chronic hepatitis: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2004 Jun; 39 Suppl 2:S584-8. View abstract
  97. Hom X, Little NR, Gardner SD, Jonas MM. Predictors of virologic response to Lamivudine treatment in children with chronic hepatitis B infection. Pediatr Infect Dis J. 2004 May; 23(5):441-5. View abstract
  98. Broderick A, Jonas MM. Management of hepatitis B in children. Clin Liver Dis. 2004 May; 8(2):387-401. View abstract
  99. Jonas MM. Nonalcoholic fatty liver disease. Adolesc Med Clin. 2004 Feb; 15(1):159-73, xi. View abstract
  100. Mayer A, Jonas MM. Hepatitis C. Textbook of Pediatric Infectious Diseases (RD Feigin, JD Cherry, GJ Demmler, and S Kaplan, eds.). 2004; 2237-51. View abstract
  101. Broderick A, Jonas MM. Hepatitis B and Hepatitis D. Textbook of Pediatric Infectious Diseases (RD Feigin, JD Cherry, GJ Demmler, and S Kaplan, eds.). 2004; 1863-83. View abstract
  102. Jonas MM. Hepatitis C in Children. Management Issues in Hepatitis C Infection (JG McHutchison ed.). 2004; 104-7. View abstract
  103. Jonas MM. Hepatitis C in Children. Hepatol Rev. 2004; 1:32-8. View abstract
  104. Broderick A, Jonas MM. Management of Hepatitis B in Children. Clinics in Liver Disease (TT Tran and P Martin, eds.). 2004; 387-401. View abstract
  105. Chang M-W, Hadzic D, Heller S, Jonas M, Kohn IJ, Negro F, Roberts E, Sibal A. Working Group Report on Acute and Chronic Hepatitis. J Pediatr Gastroenterol Nutr. 2004; 39:S584-8. View abstract
  106. Yuan Q, Jonas MM. Pediatric hepatobiliary disease. Curr Opin Gastroenterol. 2003 May; 19(3):276-80. View abstract
  107. Broderick AL, Jonas MM. Hepatitis B in children. Semin Liver Dis. 2003 Feb; 23(1):59-68. View abstract
  108. Jonas MM (Section Editor). Hepatobilary System. Rudolph's Pediatrics (C Rudolph, ed.). 2003; 1469-1518. View abstract
  109. Jonas MM, Perez-Atayde AR. Liver Disease in Infancy and Childhood. Diseases of the Liver (ER Schiff and M Sorell, eds.). 2003; 1459-98. View abstract
  110. Jonas MM. Children with hepatitis C. Hepatology. 2002 Nov; 36(5 Suppl 1):S173-8. View abstract
  111. Jonas MM. Re: ganciclovir treatment in infants with cytomegalovirus infection and cholestasis. J Pediatr Gastroenterol Nutr. 2002 Sep; 35(3):399-400; author reply 400. View abstract
  112. Jonas MM. Concerns about experimental design. J Pediatr Gastroenterol Nutr. 2002 Aug; 35(2):234. View abstract
  113. Jonas MM, Kelley DA, Mizerski J, Badia IB, Areias JA, Schwarz KB, Little NR, Greensmith MJ, Gardner SD, Bell MS, Sokal EM. Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med. 2002 May 30; 346(22):1706-13. View abstract
  114. Jonas MM. Children with Hepatitis C. Hepatology (Proceedings of NIH Consensus Conference on Hepatitis C). 2002; 36 (Suppl):S173-8. View abstract
  115. Razvi S, Schneider L, Jonas MM, Cunningham-Rundles C. Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency. Clin Immunol. 2001 Dec; 101(3):284-8. View abstract
  116. Jonas MM. Challenges in the treatment of hepatitis C in children. Clin Liver Dis. 2001 Nov; 5(4):1063-71. View abstract
  117. Jonas M, Neal KR, Abercrombie JF, Scholefield JH. A randomized trial of oral vs. topical diltiazem for chronic anal fissures. Dis Colon Rectum. 2001 Aug; 44(8):1074-8. View abstract
  118. Jonas M, Scholefield JH. Anal Fissure. Gastroenterol Clin North Am. 2001 Mar; 30(1):167-81. View abstract
  119. Burns JL, Griffith A, Barry JJ, Jonas M, Chi EY. Transcytosis of gastrointestinal epithelial cells by Escherichia coli K1. Pediatr Res. 2001 Jan; 49(1):30-7. View abstract
  120. Jonas MM, Graeme-Cook FM. A 17-year-old girl with vomiting, jaundice and weight loss. Case records of the Massachusetts General Hospital. N Engl J Med. 2001; 344:591-9. View abstract
  121. Jonas MM, Perez-Atayde AR. Fibrocystic Liver Diseases. Liver Disease in Children (FJ Suchy, RJ Sokol, and WF Balistreri, eds.). 2001; 899-913. View abstract
  122. Aprikyan AA, Liles WC, Rodger E, Jonas M, Chi EY, Dale DC. Impaired survival of bone marrow hematopoietic progenitor cells in cyclic neutropenia. Blood. 2001 Jan 01; 97(1):147-53. View abstract
  123. Nguyen D, Buonomo C, Jonas M. Image of the month. Diagnosis of cutis laxa. Gastroenterology. 2000 Dec; 119(6):1430;1804. View abstract
  124. Jonas MM. Viral hepatitis. From prevention to antivirals. Clin Liver Dis. 2000 Nov; 4(4):849-77. View abstract
  125. Berg CL, Jonas MM, Gollan JL. Treatment of genetic hemochromatosis, Wilson Disease, and other metabolic diseases of the liver. Therapy of Digestive Disorders (MM Wolfe, ed.). 2000; 257-88. View abstract
  126. Jonas MM. Hepatitis C in Children. Hepatitis C (TJ Liang and JH Hoofnagle, eds.). 2000; 389-403. View abstract
  127. Jonas MM. Viral Hepatitis- From Prevention to Antivirals. Clinics in Liver Disease (JA Bezerra and WF Balistreri, eds.). 2000; 849-77. View abstract
  128. Hom XB, Jonas MM. Sources of viral hepatitis in children. Viral Hepatitis Rev. 2000; 6:47-64. View abstract
  129. Jonas MM. Treatment of chronic hepatitis C in pediatric patients. Clin Liver Dis. 1999 Nov; 3(4):855-67. View abstract
  130. Jonas MM. Hepatitis C infection in children. N Engl J Med. 1999 Sep 16; 341(12):912-3. View abstract
  131. 35th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 1999. Diabetologia. 1999 Aug; 42(Suppl 1):A1-A330. View abstract
  132. Varela-Fascinetto G, Treacy SJ, Lillehei CW, Jonas MM, Lund DP, Kevy SV, Pérez A, Zurakowski D, Vacanti JP. Long-term results in pediatric ABO-incompatible liver transplantation. Transplant Proc. 1999 Feb-Mar; 31(1-2):467-8. View abstract
  133. Linton RA, Turtle M, Band DM, O'Brien TK, Jonas MM, Linton NW. A new technique for measuring cardiac output and shunt fraction during venovenous extracorporeal membrane oxygenation. Perfusion. 1999 Jan; 14(1):43-7. View abstract
  134. Siafakas C, Jonas MM. Neonatal Hepatitis. Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management. 1999; 553-67. View abstract
  135. Smith S, Skerrett SJ, Chi EY, Jonas M, Mohler K, Wilson CB. The locus of tumor necrosis factor-alpha action in lung inflammation. Am J Respir Cell Mol Biol. 1998 Dec; 19(6):881-91. View abstract
  136. Siafakas CG, Jonas MM, Alexander S, Herrin J, Furuta GT. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease. Am J Gastroenterol. 1998 Dec; 93(12):2544-6. View abstract
  137. Teitelbaum JE, Perez-Atayde AR, Cohen M, Bousvaros A, Jonas MM. Minocycline-related autoimmune hepatitis: case series and literature review. Arch Pediatr Adolesc Med. 1998 Nov; 152(11):1132-6. View abstract
  138. Badizadegan K, Jonas MM, Ott MJ, Nelson SP, Perez-Atayde AR. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology. 1998 Nov; 28(5):1416-23. View abstract
  139. Winram SB, Jonas M, Chi E, Rubens CE. Characterization of group B streptococcal invasion of human chorion and amnion epithelial cells In vitro. Infect Immun. 1998 Oct; 66(10):4932-41. View abstract
  140. Srivastava M, Perez-Atayde A, Jonas MM. Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child. Gastroenterology. 1998 Sep; 115(3):743-6. View abstract
  141. Kim SZ, Marz PL, Laor T, Teitelbaum J, Jonas MM, Levy HL. Elevated galactose in newborn screening due to congenital absence of the portal vein. Eur J Pediatr. 1998 Jul; 157(7):608-9. View abstract
  142. Jonas MM, Ott MJ, Nelson SP, Badizadegan K, Perez-Atayde AR. Interferon-alpha treatment of chronic hepatitis C virus infection in children. Pediatr Infect Dis J. 1998 Mar; 17(3):241-6. View abstract
  143. Laor T, Hoffer FA, Vacanti JP, Jonas MM. MR cholangiography in children after liver transplantation from living related donors. AJR Am J Roentgenol. 1998 Mar; 170(3):683-7. View abstract
  144. Linton R, Turtle M, Band D, O'Brien T, Jonas M. In vitro evaluation of a new lithium dilution method of measuring cardiac output and shunt fraction in patients undergoing venovenous extracorporeal membrane oxygenation. Crit Care Med. 1998 Jan; 26(1):174-7. View abstract
  145. Darmstadt GL, Fleckman P, Jonas M, Chi E, Rubens CE. Differentiation of cultured keratinocytes promotes the adherence of Streptococcus pyogenes. J Clin Invest. 1998 Jan 01; 101(1):128-36. View abstract
  146. Murray KF, Jonas MM. Biliary Atresia. Clinical Pediatric Gastroenterology (S Altschuler and C Liacouras, eds.). 1998; 331-9. View abstract
  147. Nizet V, Kim KS, Stins M, Jonas M, Chi EY, Nguyen D, Rubens CE. Invasion of brain microvascular endothelial cells by group B streptococci. Infect Immun. 1997 Dec; 65(12):5074-81. View abstract
  148. Lenders C, Buonomo C, Jonas MM. Image of the month. Disseminated infections, especially candidiasis in immunocompromised individuals, cat-scratch fever, and infiltrative diseases such as leukemia or lymphoma. Gastroenterology. 1997 Nov; 113(5):1432, 1815. View abstract
  149. Siafakas CG, Jonas MM, Perez-Atayde AR. Abnormal bile acid metabolism and neonatal hemochromatosis: a subset with poor prognosis. J Pediatr Gastroenterol Nutr. 1997 Sep; 25(3):321-6. View abstract
  150. Jonas MM, Robertson LM, Middleman AB. Low prevalence of antibody to hepatitis C virus in an urban adolescent population. J Pediatr. 1997 Aug; 131(2):314-6. View abstract
  151. Bresee JS, Mast EE, Coleman PJ, Baron MJ, Schonberger LB, Alter MJ, Jonas MM, Yu MY, Renzi PM, Schneider LC. Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study. JAMA. 1996 Nov 20; 276(19):1563-7. View abstract
  152. Schluger LK, Sheiner PA, Jonas M, Guarrera JV, Fiel IM, Meyers B, Berk PD. Isoniazid hepatotoxicity after orthotopic liver transplantation. Mt Sinai J Med. 1996 Oct-Nov; 63(5-6):364-9. View abstract
  153. Burns JL, Jonas M, Chi EY, Clark DK, Berger A, Griffith A. Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect Immun. 1996 Oct; 64(10):4054-9. View abstract
  154. Jonas MM. Interferon-alpha for viral hepatitis. J Pediatr Gastroenterol Nutr. 1996 Aug; 23(2):93-106. View abstract
  155. Jonas MM, Baron MJ, Bresee JS, Schneider LC. Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin. Pediatrics. 1996 Aug; 98(2 Pt 1):211-5. View abstract
  156. Shamberger RC, Leichtner AM, Jonas MM, LaQuaglia MP. Long-term hepatic regeneration and function in infants and children following liver resection. J Am Coll Surg. 1996 Jun; 182(6):515-9. View abstract
  157. Nelson SP, Jonas MM. Hepatitis C infection in children who received extracorporeal membrane oxygenation. J Pediatr Surg. 1996 May; 31(5):644-8. View abstract
  158. Fishman LN, Jonas MM, Lavine JE. Update on viral hepatitis in children. Pediatr Clin North Am. 1996 Feb; 43(1):57-74. View abstract
  159. Jonas MM. Hepatitis C virus infection: clinical aspects and treatment with interferon alfa. Clin Ther. 1996; 18 Suppl B:110-25. View abstract
  160. Schneider LC, Jonas MM, Baron MJ, Mast EF, Alter MJ, Schonberger LB, Lambert S, Coleman P, Bresee JS. Intravenous immunoglobulin and hepatitis C virus: the Boston episode. Clin Ther. 1996; 18 Suppl B:108-9. View abstract
  161. Nelson SN, Jonas MM. Clinical features of liver disease. Practical Pediatric Gastroenterology (JA Walker-Smith, JR Hamilton, and WA Walker, eds.). 1996; 107-18. View abstract
  162. Jonas MM. Hepatitis C virus infection: clinical aspects and treatment with interferon-alfa. Clin Therapeut. 1996; 18 (Suppl):110-25. View abstract
  163. Jonas MM. Hepatitis B vaccination in pediatric practice. Infectious Disease in Children. 1996; 7-13. View abstract
  164. Jonas MM. Viral hepatitis. Pediatric Gastrointestinal Disease (WA Walker, PR Durie, JR Hamilton, JA Walker-Smith, and JB Watkins, eds.). 1996; 1028-51. View abstract
  165. Jonas MM. The clinical spectrum of hepatitis C virus infection. Internat Semin Paediatr Gastroenterol Nutr. 1996; 5:9-15. View abstract
  166. Wagstaff J, Jonas MM. Closing in on a "familial cholestasis gene". Hepatology. 1995 Nov; 22(5):1611-3. View abstract
  167. Miller TL, Jonas MM. Adolescent Human Immunodeficiency Virus Infection and Gastrointestinal Disease. Adolesc Med. 1995 Oct; 6(3):397-416. View abstract
  168. Jonas MM. Hereditary hemorrhagic telangiectasia. J Pediatr Gastroenterol Nutr. 1995 Feb; 20(2):238. View abstract
  169. D'Agata ID, Jonas MM. Shedding light into the black box of childhood cholestatic liver disease. Hepatology. 1995 Jan; 21(1):257-60. View abstract
  170. D'Agata ID, Jonas MM, Perez-Atayde AR, Guay-Woodford LM. Combined cystic disease of the liver and kidney. Semin Liver Dis. 1994 Aug; 14(3):215-28. View abstract
  171. Bross DA, Perez-Atayde A, Mandell VS, Hyams JS, Jonas MM. Hereditary hemorrhagic telangiectasia presenting in early childhood. J Pediatr Gastroenterol Nutr. 1994 May; 18(4):497-500. View abstract
  172. Perez-Atayde AR, Sirlin SM, Jonas M. Coombs-positive autoimmune hemolytic anemia and postinfantile giant cell hepatitis in children. Pediatr Pathol. 1994 Jan-Feb; 14(1):69-77. View abstract
  173. Jonas MM, R Siegel. Hepatitis B infection in Children. AAP Pediatric Update (monograph and audiocassette) (WF Balistreri, moderator). 1994. View abstract
  174. Powelson JA, Cosimi AB, Lewis WD, Rohrer RJ, Freeman RB, Vacanti JP, Jonas M, Lorber MI, Marks WH, Bradley J, et al. Hepatic retransplantation in New England--a regional experience and survival model. Transplantation. 1993 Apr; 55(4):802-6. View abstract
  175. Jonas MM, Walker WA. Disorders of the biliary tree. Gellis and Kagan's Current Pediatric Therapy (FD Burg, J Ingelfinger, and E Wald, eds.). 1993. View abstract
  176. Jonas MM. Bacterial overgrowth in the small bowel. Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management (R Wyllie and J Hyams, eds.). 1993. View abstract
  177. Jonas MM, Zilleruelo GE, LaRue SI, Abitbol C, Strauss J, Lu Y. Hepatitis C infection in a pediatric dialysis population. Pediatrics. 1992 Apr; 89(4 Pt 2):707-9. View abstract
  178. Jonas MM, Bell MD, Eidson MS, Koutouby R, Hensley GT. Congenital diabetes mellitus and fatal secretory diarrhea in two infants. J Pediatr Gastroenterol Nutr. 1991 Nov; 13(4):415-25. View abstract
  179. Jonas MM, Ragin L, Silva MO. Membranous glomerulonephritis and chronic persistent hepatitis B in a child: treatment with recombinant interferon alfa. J Pediatr. 1991 Nov; 119(5):818-20. View abstract
  180. Ranjan D, Purser R, Jonas M, Yrizzary J, Borgeson M, Miller J, Burke G. Isolated splenic vein thrombosis as a cause of massive upper-gastrointestinal bleeding following orthotopic liver transplantation. Transplantation. 1991 Oct; 52(4):725-7. View abstract
  181. Sachse RE, Burke GW, Jonas M, Milgrom M, Miller J. Benign pneumatosis intestinalis with subcutaneous emphysema in a liver transplant recipient. Am J Gastroenterol. 1990 Jul; 85(7):876-9. View abstract
  182. Jonas MM, Reddy RK, DeMedina M, Schiff ER. Hepatitis B infection in a large municipal obstetrical population: characterization and prevention of perinatal transmission. Am J Gastroenterol. 1990 Mar; 85(3):277-80. View abstract
  183. Burke GW III, Ranjan D, Jonas MM, Koleilat N, Miller J. Current trends in immunosuppression in pediatric orthotopic liver transplantation. Internat Pediatr. 1990; 5:18-22. View abstract
  184. Jonas MM, Roldan EO, Lyons HJ, Fojaco RM, Reddy RK. Histopathologic features of the liver in pediatric acquired immune deficiency syndrome. J Pediatr Gastroenterol Nutr. 1989 Jul; 9(1):73-81. View abstract
  185. Jonas MM. Gastrointestinal disease symptoms. Curr Opin Pediatr. 1989; 1:345-9. View abstract
  186. Jayachandar J, Frank JL, Jonas MM. Isolated intestinal myopathy resembling progressive systemic sclerosis in a child. Gastroenterology. 1988 Oct; 95(4):1114-8. View abstract
  187. Jonas MM, Eidson MS. Propylthiouracil hepatotoxicity: two pediatric cases and review of the literature. J Pediatr Gastroenterol Nutr. 1988 Sep-Oct; 7(5):776-9. View abstract
  188. Jonas MM, Kaweblum YA, Fojaco R. Neonatal hemochromatosis: failure of deferoxamine therapy. J Pediatr Gastroenterol Nutr. 1987 Nov-Dec; 6(6):984-8. View abstract
  189. Jonas MM, Schiff ER, O'Sullivan MJ, de Medina M, Reddy KR, Jeffers LJ, Fayne T, Roach KC, Steele BW. Failure of Centers for Disease Control criteria to identify hepatitis B infection in a large municipal obstetrical population. Ann Intern Med. 1987 Sep; 107(3):335-7. View abstract
  190. Jonas MM. Inflammatory bowel disease in children and adolescents. Pract Gastroenterol. 1987; 11:37-42. View abstract
  191. Jonas MM, Montgomery RK, Grand RJ. Intestinal lactase synthesis during postnatal development in the rat. Pediatr Res. 1985 Sep; 19(9):956-62. View abstract
  192. Jonas MM, Grand RJ. The abdomen and gastrointestinal tract (sections). Pediatrics (M Ziai, ed.). 1984; 292-4. View abstract
  193. Jonas MM, Perrault J, Grand RJ, Dickson ER. Clinical response to penicillamine in cholestatic liver disease. Extrahepatic biliary atresia (F Daum, ed.). 1983; 227-32. View abstract
  194. Montgomery RK, Jonas MM, Grand RJ. Intestinal disaccharidases: structure, function and deficiency. Carbohydrate intolerance in infancy (F Lifshitz, ed.). 1982; 75-92. View abstract